Robert E. Davis
178Patents
30h-index
101Co-inventors
93Inventor score
Filing activity: Apr 22, 1975 → Jun 12, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6268398A | Compounds and methods for treating mitochondria-associated diseases | Human Necessities | 117 | Expired |
| US4569310A | Pulsing combustion | Emerging Cross-Sectional Technologies | 115 | Expired |
| US4479484A | Pulsing combustion | Performing Operations; Transporting | 91 | Expired |
| US4651712A | Pulsing combustion | Mechanical Engineering; Lighting; Heating | 90 | Expired |
| US8993572B2 | Pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines derivatives and [1,4]oxazino[2,3,4-hi]pyrido[4,3-b]indole derivatives | Chemistry; Metallurgy | 85 | Active |
| US4488865A | Pulsing combustion | Emerging Cross-Sectional Technologies | 84 | Expired |
| US4637792A | Pulsing combustion | Performing Operations; Transporting | 83 | Expired |
| US4480985A | Pulsing combustion | Emerging Cross-Sectional Technologies | 78 | Expired |
| US9371324B2 | Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders | Chemistry; Metallurgy | 75 | Active |
| US9708322B2 | Substituted pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity | Chemistry; Metallurgy | 68 | Active |
| US9428506B2 | Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for the treatment of nervous system disorders | Chemistry; Metallurgy | 67 | Active |
| US4929734A | Tetrahydropyridine oxime compounds | Human Necessities | 66 | Expired |
| US9745300B2 | Organic compounds | Chemistry; Metallurgy | 65 | Active |
| US9956227B2 | Method for the treatment of residual symptoms of schizophrenia | Human Necessities | 63 | Active |
| US5290705A | Speciman support for optical analysis | Physics | 57 | Expired |
| US10077267B2 | Organic compounds | Chemistry; Metallurgy | 55 | Active |
| US10072010B2 | Substituted pyrido[3′,4′:4,5]pyrrolo[1,2,3-de]quinoxalines for inhibiting serotonin reuptake transporter activity | Chemistry; Metallurgy | 45 | Active |
| US7601740B2 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Chemistry; Metallurgy | 43 | Active |
| US4407300A | Potentiometric diagnosis of cancer in vivo | Human Necessities | 42 | Expired |
| US7863296B2 | Selective serotonin receptor inverse agonists as therapeutics for disease | Human Necessities | 41 | Active |
| US10322134B2 | Methods | Human Necessities | 40 | Active |
| US8463953B2 | System and method for integrating devices for servicing a device-under-service | Physics | 39 | Active |
| US5921392A | Package with exposed articles | Performing Operations; Transporting | 39 | Expired |
| US10036236B1 | Setting tool igniter system and method | Mechanical Engineering; Lighting; Heating | 38 | Active |
| US8921393B2 | Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases | Chemistry; Metallurgy | 37 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.